Eagle Pharmaceuticals, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US2697961082
USD
0.70
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Dec'17
No of Months
12
12
12
12
12
12
Operating Income
316.00
171.00
187.00
195.00
213.00
236.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
316.00
171.00
187.00
195.00
213.00
236.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
4.00
1.00
2.00
2.00
2.00
1.00
General and Administration Expenses
93.00
75.00
78.00
76.00
60.00
71.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
223.00
168.00
154.00
174.00
166.00
160.00
Operating Profit (PBDIT) excl Other Income
93.00
2.00
32.00
21.00
46.00
75.00
Other Income
-7.00
0.00
-7.00
2.00
0.00
0.00
Operating Profit (PBDIT)
98.00
8.00
30.00
29.00
50.00
79.00
Interest
4.00
1.00
2.00
2.00
2.00
1.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
13.00
4.00
4.00
4.00
3.00
3.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
61.00
-4.00
22.00
21.00
34.00
72.00
Provision for Tax
25.00
4.00
10.00
7.00
2.00
21.00
Profit After Tax
35.00
-8.00
11.00
14.00
31.00
51.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.73
-0.66
0.87
1.01
2.09
3.27
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2022 is 84.56% vs -8.66% in Dec 2021

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2022 is 3,278.84% vs -91.60% in Dec 2021

stock-summary

Interest

YoY Growth in year ended Dec 2022 is 147.40% vs -36.55% in Dec 2021

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2022 is 513.14% vs -171.96% in Dec 2021

Compare Profit and Loss Results of Eagle Pharmaceuticals, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
316.00
0.00
316.00
0%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
316.00
0.00
316.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
4.00
0.00
4.00
0%
General and Administration Expenses
93.00
34.00
59.00
173.53%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
223.00
111.00
112.00
100.90%
Operating Profit (PBDIT) excl Other Income
93.00
-111.00
204.00
183.78%
Other Income
-7.00
17.00
-24.00
-141.18%
Operating Profit (PBDIT)
98.00
-94.00
192.00
204.26%
Interest
4.00
0.00
4.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
13.00
0.00
13.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
61.00
-94.00
155.00
164.89%
Provision for Tax
25.00
0.00
25.00
0%
Profit After Tax
35.00
-94.00
129.00
137.23%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.728
-1.6784
4.41
262.54%
Profit And Loss - Net Sales
Net Sales 316.61 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 84.56% vs -8.66% in Dec 2021

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 93.56 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 3,278.84% vs -91.60% in Dec 2021

Profit And Loss - Interest
Interest 4.04 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 147.40% vs -36.55% in Dec 2021

Profit And Loss - Profit After Tax
Profit After Tax 35.64 Million
in Dec 2022

Figures in Million
stock-summary

YoY Growth in year ended Dec 2022 is 513.14% vs -171.96% in Dec 2021